Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/wnl.0000000000011626
PubMed Identifier: 33597289
Publication URI: http://europepmc.org/abstract/MED/33597289
Type: Journal Article/Review
Volume: 96
Parent Publication: Neurology
Issue: 12
ISSN: 0028-3878